Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine versus sufentanil for postoperative analgesia after knee resurfacing surgery
ChiCTR2400094524Phase 4Recruiting
- Sponsor
- Henan Provincial People's Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oliceridine in acute postoperative pain (2 arms), sponsored by Henan Provincial People's Hospital. Primary endpoint: SPID-48. Started Dec 2024; status: recruiting.
02
Drugs
oliceridine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2400094524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094524.